PROCEPT BioRobotics Corporation Capital Expenditures
PROCEPT BioRobotics Corporation (PRCT) reported Capital Expenditures of $5.87 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-05
- PROCEPT BioRobotics Corporation payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $2.95M, a 5.39% increase year-over-year.
- PROCEPT BioRobotics Corporation payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $2.91M, a 58.71% increase year-over-year.
- PROCEPT BioRobotics Corporation payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $1.85M, a 57.58% increase year-over-year.
- PROCEPT BioRobotics Corporation payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $2.87M, a 1065.85% increase year-over-year.
- PROCEPT BioRobotics Corporation payments to acquire property, plant, and equipment for fiscal 2025 was $9.36M, a 112.20% increase from fiscal 2024.
- PROCEPT BioRobotics Corporation payments to acquire property, plant, and equipment for fiscal 2024 was $4.41M, a 82.51% decline from fiscal 2023.
- PROCEPT BioRobotics Corporation payments to acquire property, plant, and equipment for fiscal 2023 was $25.21M, a 850.09% increase from fiscal 2022.
- PROCEPT BioRobotics Corporation payments to acquire property, plant, and equipment for fiscal 2022 was $2.65M, a 348.14% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.87M 10-Q · filed 2026-08-05 | $7.72M derived: sum of 3 quarters · filed 2026-08-05 | $10.59M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $2.91M 10-Q · filed 2026-04-30 | $4.76M derived: sum of 2 quarters · filed 2026-04-30 | $7.63M derived: sum of 3 quarters · filed 2026-04-30 | $10.43M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.72M derived: sum of 2 quarters · filed 2026-02-26 | $7.52M derived: sum of 3 quarters · filed 2026-08-05 | $9.36M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $5.67M derived: sum of 2 quarters · filed 2026-08-05 | $7.51M 10-Q · filed 2025-11-05 | $8.68M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $4.64M 10-Q · filed 2026-08-05 | $5.81M derived: sum of 3 quarters · filed 2026-08-05 | $6.06M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.84M 10-Q · filed 2026-04-30 | $3.01M derived: sum of 2 quarters · filed 2026-04-30 | $3.26M derived: sum of 3 quarters · filed 2026-04-30 | $4.30M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.42M derived: sum of 2 quarters · filed 2026-02-26 | $2.46M derived: sum of 3 quarters · filed 2026-02-26 | $4.41M 10-K · filed 2026-02-26 |
| 2024-09-30 | $246.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.29M derived: sum of 2 quarters · filed 2025-11-05 | $3.23M 10-Q · filed 2025-11-05 | $11.95M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.99M 10-Q · filed 2025-08-07 | $11.70M derived: sum of 3 quarters · filed 2026-02-26 | $17.48M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.95M 10-Q · filed 2025-05-02 | $10.66M derived: sum of 2 quarters · filed 2026-02-26 | $16.44M derived: sum of 3 quarters · filed 2026-02-26 | $21.81M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $8.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $14.49M derived: sum of 2 quarters · filed 2026-02-26 | $19.87M derived: sum of 3 quarters · filed 2026-02-26 | $25.21M 10-K · filed 2026-02-26 |
| 2023-09-30 | $5.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28 | $11.15M derived: sum of 2 quarters · filed 2024-10-28 | $16.49M 10-Q · filed 2024-10-28 | $17.36M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $5.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $10.71M 10-Q · filed 2024-08-02 | $11.58M derived: sum of 3 quarters · filed 2025-02-27 | $13.09M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $5.34M 10-Q · filed 2024-05-02 | $6.21M derived: sum of 2 quarters · filed 2025-02-27 | $7.72M derived: sum of 3 quarters · filed 2025-02-27 | $7.94M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $866.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.38M derived: sum of 2 quarters · filed 2025-02-27 | $2.60M derived: sum of 3 quarters · filed 2025-02-27 | $2.65M 10-K · filed 2025-02-27 |
| 2022-09-30 | $1.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.73M derived: sum of 2 quarters · filed 2023-11-02 | $1.79M 10-Q · filed 2023-11-02 | $2.12M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $218.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $273.00K 10-Q · filed 2023-07-28 | $605.00K derived: sum of 3 quarters · filed 2024-02-28 | $716.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $55.00K 10-Q · filed 2023-05-04 | $387.00K derived: sum of 2 quarters · filed 2024-02-28 | $498.00K derived: sum of 3 quarters · filed 2024-02-28 | $608.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $332.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $443.00K derived: sum of 2 quarters · filed 2024-02-28 | $553.00K derived: sum of 3 quarters · filed 2024-02-28 | $592.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | $111.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $221.00K derived: sum of 2 quarters · filed 2022-11-04 | $260.00K 10-Q · filed 2022-11-04 | $269.00K derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $110.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $149.00K 10-Q · filed 2022-08-05 | $158.00K derived: sum of 3 quarters · filed 2022-08-05 | |
| 2021-03-31 | $39.00K 10-Q · filed 2022-05-06 | $48.00K derived: sum of 2 quarters · filed 2022-05-06 | ||
| 2020-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $233.00K 10-K · filed 2022-03-22 | ||
| 2020-09-30 | $224.00K 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |